Newborn Pulse Oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns

HTA Council Recommendation (as of 09 July 2025) The HTA Council positively recommends  newborn pulse oximetry as a screening test for CCHD among asymptomatic, apparently healthy newborns for financing of DOH and/or PhilHealth.  In addition to this, the HTA Council recommends that the Department of Health refer to the WHO-UNICEF  technical specifications when selecting the continue reading : Newborn Pulse Oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns

HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester

HTA Council Recommendation (as of 18 June 2025) The HTA Council positively recommends the government financing of HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester The HTA Council strongly recommends that implementation of HIV health technologies should follow the WHO continue reading : HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester

HIV Self Test Kit for screening of HIV infection in adults belonging to HIV and sexually transmitted infection key populations

HTA Council Recommendation (as of 18 June 2025) The HTA Council positively recommends the government financing of HIV Self Test Kit for screening of HIV infection in adults belonging to HIV and sexually transmitted infection key populations*. The HTA Council strongly recommends that implementation of HIV health technologies should follow the WHO testing strategy for continue reading : HIV Self Test Kit for screening of HIV infection in adults belonging to HIV and sexually transmitted infection key populations

Lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosis of active tuberculosis infection in human immunodeficiency virus (HIV) patient

HTA Council Recommendation (as of 9 July 2025) The HTA Council positively recommends the government financing of Lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosis of active tuberculosis infection in human immunodeficiency virus (HIV) patient The HTA Council recommends that the Department of Health refer to existing and future WHO target product profiles (TPPs) when continue reading : Lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosis of active tuberculosis infection in human immunodeficiency virus (HIV) patient

Cartridge-based Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Test for diagnosis of extensively drug-resistant tuberculosis (XDR-TB)

HTA Council Recommendation (as of 9 July 2025) The HTA Council positively recommends the government financing of Cartridge-based Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Test for diagnosis of extensively drug-resistant tuberculosis (XDR-TB) The HTA Council recommends that the Department of Health refer to existing and future WHO target product profiles (TPPs) when selecting tests for procurement. continue reading : Cartridge-based Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Test for diagnosis of extensively drug-resistant tuberculosis (XDR-TB)